The use of a two-tiered testing strategy for the simultaneous detection of small EGFR mutations and EGFR amplification in lung cancer.
Lung cancer is the leading cause of cancer-related death worldwide. Recent progress in lung cancer diagnosis and treatment has been achieved due to a better understanding the molecular mechanisms of the disease and the identification of biomarkers that allow more specific cancer treatments. One of t...
Main Authors: | Marzena Anna Lewandowska, Karol Czubak, Katarzyna Klonowska, Wojciech Jozwicki, Janusz Kowalewski, Piotr Kozlowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4342230?pdf=render |
Similar Items
-
Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
by: Masaharu Nomura, et al.
Published: (2007-04-01) -
Effect of EGFR-TKI on Lymphangiogenesis of Lung Cancer with EGFR Mutation
by: Minghui CAI, et al.
Published: (2014-12-01) -
EGFR Mutations and Lung Cancer.
Published: (2005-11-01) -
EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco
by: Nadia Senhaji, et al.
Published: (2017-01-01) -
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation
by: Rossella Bruno, et al.
Published: (2021-06-01)